These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6203808)

  • 1. [Antileukemic activity of liposome forms of cytosine arabinoside and cyclocytidine].
    Reshchikov VP; Afonin NI; Ermakov LN; Fertukova NM; Oksinoĭd OE
    Gematol Transfuziol; 1984; 29(5):49-51. PubMed ID: 6203808
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies of the L1210 antileukemic activity of O-2,2'-cyclocytidine, monoacetate (anhydro-ara-C; NSC-129220)--comparison with cytosine arabinoside (NSC-63878) with respect to treatment schedule dependency.
    Venditti JM; Baratta MC; Greenberg NH; Abbott BJ; Kline I
    Cancer Chemother Rep; 1972 Aug; 56(4):483-92. PubMed ID: 5081591
    [No Abstract]   [Full Text] [Related]  

  • 3. Enhancement of the cancer chemotherapeutic effect of cytosine arabinoside entrapped in liposomes on mouse leukemia L-1210.
    Kobayashi T; Tsukagoshi S; Sakurai Y
    Gan; 1975 Dec; 66(6):719-20. PubMed ID: 1225724
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of cholesterol in enhancing the antitumor activity of cytosine arabinoside entrapped in liposomes.
    Mayhew E; Rustum YM; Szoka F; Papahadjopoulos D
    Cancer Treat Rep; 1979; 63(11-12):1923-8. PubMed ID: 526925
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of mitotic cycle inhibitors on the antileukemic activity of cytosine arabinoside (NSC-63878) in mice bearing leukemia L1210.
    Vadlamudi S; Goldin A
    Cancer Chemother Rep; 1971 Dec; 55(5):547-55. PubMed ID: 5159846
    [No Abstract]   [Full Text] [Related]  

  • 6. [Influencing factors in the leakage of liposome and arabinoside cytosine (ARA-C) entrapped in liposomes in treatment of L1210 mouse leukemia].
    Fu NW
    Zhonghua Zhong Liu Za Zhi; 1985 Jul; 7(4):250-3. PubMed ID: 4085312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of murine L1210 lymphoid leukemia and melanoma B16 with lipophilic cytosine arabinoside prodrugs incorporated into unilamellar liposomes.
    Rubas W; Supersaxo A; Weder HG; Hartmann HR; Hengartner H; Schott H; Schwendener R
    Int J Cancer; 1986 Jan; 37(1):149-54. PubMed ID: 3941019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Selective treatment of leukemia L1210 with combination of deoxycytidine and lethal doses of cytosine arabinoside].
    Bukhman VM; Lichinitser MR; Svet-Moldavskiĭ GIa; Mkheidze DM
    Biull Eksp Biol Med; 1978 Mar; 85(3):340-3. PubMed ID: 276385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of route of administration on antileukemic activity of cytosine arabinoside (NSC-63878) in advanced leukemia L1210 in mice.
    Kline I; Tyrer DD; Gang M; Venditti JM; Goldin A
    Cancer Chemother Rep; 1968 Apr; 52(3):399-404. PubMed ID: 5670722
    [No Abstract]   [Full Text] [Related]  

  • 10. Sequential chemotherapy with cyclophosphamide (NSC-26271) and cytosine arabinoside (NSC-63878) in mice with advanced leukemia L1210.
    Hoffman GS; Kline I; Gang M; Tyrer DD; Goldin A; Mantel N; Venditti JM
    Cancer Chemother Rep; 1969 Oct; 53(5):265-71. PubMed ID: 5377613
    [No Abstract]   [Full Text] [Related]  

  • 11. [Liposomes as carriers of lipophilic cytosine arabinoside and fluorodeoxyuridine derivatives. Their cytostatic effect and possibilities of tumor cell specific therapy].
    Schwendener RA; Schott H; Hartmann HR; Supersaxo A; Rubas W; Hengartner H
    Onkologie; 1987 Aug; 10(4):232-9. PubMed ID: 2959889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of cyclocytidine in children with advanced acute leukemia and solid tumors.
    Finklestein JZ; Higgins G; Krivit W; Hammond D
    Cancer Treat Rep; 1979 Aug; 63(8):1331-3. PubMed ID: 89907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-related synergism of cytosine arabinoside and methotrexate against murine leukemia L1210.
    Avery TL; Roberts D
    Eur J Cancer (1965); 1974 Jul; 10(7):425-9. PubMed ID: 4457345
    [No Abstract]   [Full Text] [Related]  

  • 14. A computer model for tumor growth and chemotherapy, and its application to L1210 leukemia treated with cytosine arabinoside (NSC-63878).
    Shackney SE
    Cancer Chemother Rep; 1970 Dec; 54(6):399-429. PubMed ID: 5527022
    [No Abstract]   [Full Text] [Related]  

  • 15. Experimental study on antitumor activity and pharmacokinetics of cytosine arabinoside, cyclocytidine and BH-AC.
    Takenaka T; Kimura K
    Nihon Ketsueki Gakkai Zasshi; 1984 Jul; 47(4):938-49. PubMed ID: 6209907
    [No Abstract]   [Full Text] [Related]  

  • 16. Response of L1210 to combinations of cytosine arabinoside and VM-26 or VP16-213.
    Rivera G; Avery T; Roberts DW
    Eur J Cancer (1965); 1975 Sep; 11(9):639-47. PubMed ID: 1220978
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative studies of cyclocytidine (NSC-145668) and cytosine arabinoside (NSC-63878) in mice.
    Liss RH; Neil GL
    Cancer Chemother Rep; 1975; 59(3):501-13. PubMed ID: 1203880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronochemotherapy of L1210 leukemic mice with cytosine arabinoside or cyclophosphamide.
    Rose WC; Trader MW; Laster WR; Schabel FM
    Cancer Treat Rep; 1978 Sep; 62(9):1337-49. PubMed ID: 688277
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experimental study on the correlation between the antitumor activity and pharmacokinetics of cytosine arabinoside (Ara-C) and N4-behenoyl-1-beta-D-arabinofuranosylcytosine (BH-AC)].
    Takenaka T; Kimura K
    Nihon Gan Chiryo Gakkai Shi; 1985 Dec; 20(10):2322-8. PubMed ID: 3831176
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of different doses of methotrexate (NSC-740), cytosine arabinoside (NSC-63878), and cyclophosphamide (NSC-26271) on drug resistance in mice with L1210 leukemia.
    Schmid FA; Hutchison DJ
    Cancer Chemother Rep; 1972 Aug; 56(4):473-81. PubMed ID: 5081590
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.